Goldman Sachs Posts Strong Fourth Quarter Earnings Amid Deal Activity
Goldman Sachs reported a 12% rise in Q4 net income to $4.6 billion, with dealmaking fees up 25%. CEO David Solomon noted high client engagement and momentum into 2026.
Author
Latest reporting and analysis by Mrs. Georgianna Kulas Sr..
Goldman Sachs reported a 12% rise in Q4 net income to $4.6 billion, with dealmaking fees up 25%. CEO David Solomon noted high client engagement and momentum into 2026.
A stay-at-home mom in Omaha called The Ramsey Show to describe financial imbalance with her partner, revealing she moved for him, closed her business, receives no salary, and has no joint account access while caring for their child.
JPMorgan CEO Jamie Dimon says Trump's criticism of Fed Chair Jerome Powell threatens central bank independence and could raise inflation and interest rates. Powell faces a DOJ investigation over Fed HQ renovations.
Chipotle Mexican Grill reaffirmed its full-year 2025 guidance on Jan. 12, projecting low single-digit same-store sales decline and announcing leadership changes. CEO Scott Boatwright expressed confidence in the 2026 strategic plan.
Morningstar's Christine Benz details an eight-step process for reviewing investment portfolios, covering documentation, savings rates, asset allocation, and tax efficiency.
JPMorgan forecasts the Federal Reserve will raise interest rates in Q3 2027, contrasting with crypto analysts' expectations of cuts. Bitcoin's sensitivity to rate expectations is noted.
President Trump announced a plan to prohibit large investment firms from purchasing single-family homes, aiming to ease housing inventory. Experts debate its impact, noting institutional investors hold a small market share, while local building restrictions and regulatory costs are cited as major affordability challenges.
TD Cowen lowered its price target for Colgate-Palmolive to $86 on Jan 8, 2026, while Piper Sandler raised its target to $88 on Jan 7, with both firms commenting on the company's 2026 prospects.
Citi lowered Sysco's price target to $81 on Jan 7, 2026, while Barclays raised its target to $88. The stock is up 1.11% YTD as of Jan 9.